Prescription drugmakers are on track to exceed their lobbying spending from last year, according to third quarter disclosure forms that were due Monday.
In 2017, the industry spent $171.6 million. During the first half of 2018, drugmakers spent almost $95.4 million, putting them on pace to top last year’s total.
Updated 3:31 p.m. | Top Republican lawmakers have no plans to examine the alleged influence that a trio of President Donald Trump’s friends have at the Department of Veterans Affairs, even as Democrats call for an investigation.
The controversy peaked in recent weeks after reports that Marvel Entertainment Chairman Ike Perlmutter, Palm Beach doctor Bruce Moskowitz and D.C. lawyer Marc Sherman hold undue sway with VA leadership, including senior adviser Peter O’Rourke, who formerly served as acting secretary. Liberal veterans group VoteVets filed a lawsuit against the administration last week, claiming the VA is violating federal protocol related to private influence in matters of federal policy.
Family caregivers seeking help from the Department of Veterans Affairs encountered extended wait times and spotty aid from the agency, according to a new report from the VA’s Office of Inspector General.
The OIG investigation found that 65 percent of the more than 1,800 applicants between January and September 2017 were forced to wait longer than the required 45-day timeframe to be approved for the program. Fifty-five percent of the applicants waited between three and six months for approval, while 14 percent waited even longer, according to thereport released Thursday.
The House Ways and Means Committee said it would continue exploring ways to reduce regulations in Medicare, after issuing a report last week on its conversations with health care providers.
While light on specifics, the committee said it is engaging in “ongoing dialogue” with the Trump administration over where legislative solutions are needed to reduce what it deems unnecessary regulations.
The number of women giving birth with opioid use disorder quadrupled between 1999 and 2014, a new report from the Centers for Disease Control and Prevention shows.
The increase underscores the severity of the country’s opioid epidemic as a legislative package aimed at helping states curb addiction rates idles in the Senate. Newborns exposed to drugs while in the womb can suffer severe complications, including withdrawal, preterm birth and death.
The Senate Veterans’ Affairs Committee seems poised to advance a popular bipartisan bill extending disability benefits to Vietnam veterans who claim they were exposed to Agent Orange. But Department of Veterans Affairs officials said Wednesday the agency opposes the measure.
Lawmakers on both sides of the aisle expressed strong support for the legislation at a hearing Wednesday, questioning whether the VA adequately considers applications from vets who served in ocean vessels claiming exposure.
His confirmation Monday drew scrutiny and nine dissenters. Now Veterans Affairs Secretary Robert Wilkie must face the real challenge: repairing the sprawling agency that serves the nation’s veterans, including 9 million who receive health care benefits through the department.
The second-largest federal agency is embarking on two major initiatives — a reorganization of its private medical care options and a $15.8 billion electronic health records project — at the same time that it seeks to fill key positions overseeing them.
A federal watchdog is recommending the Department of Health and Human Services recoup $341,000 associated with former Secretary Tom Price’s travel expenses.
The HHS Office of the Inspector General released Thursday an audit that found 20 of 21 trips Price and other HHS officials took during his time in office did not comply with federal requirements. Price, a hardline fiscal conservative during his time in Congress, resigned last September after it was revealed that he regularly chartered private planes for routine business trips.
The Department of Veterans Affairs is considering removing an exclusion on medical coverage for transgender services as the Trump administration battles multiple lawsuits against its transgender policies.
The VA released a request for comment Friday in response to a 2016 petition it received under former President Barack Obama to allow coverage of sex reassignment surgery. The petitioners, Dee Fulcher, Giuliano Silva and Transgender Veterans of America, eventually sued the Trump administration in 2017 in the U.S. Court of Appeals for the Federal Circuit. The case is ongoing.
The Trump administration on Tuesday finalized a rule expanding the availability of alternative insurance plans that do not meet the 2010 health care law’s requirements despite objections from consumer advocates and the industry.
The rule will extend so-called association health plans, which allow insurance companies to skirt benefit requirements and other parts of the 2010 law. President Donald Trump heralded the new rule in a speech Tuesday to the National Federation of Independent Business trade group, or NFIB.
The Department of Veterans Affairs will face heavy scrutiny as it implements a major overhaul to its health care programs that President Donald Trump is expected to sign into law this week.
The bill, which moved through both chambers by wide bipartisan margins, would combine the VA’s seven programs for private medical care into one to streamline and simplify costs and access for veterans. The legislation would also extend the so-called Veterans Choice Program for one year, allowing veterans to seek care outside the VA under certain circumstances in the meantime.
President Donald Trump has instructed trade ambassador Robert Lighthizer to grant the drug industry’s wish of making pharmaceutical prices a “top priority” in negotiations with other countries.
Trump revealed the instruction during a Friday announcement unveiling the administration’s overall strategy for lowering drug costs.
An upcoming Trump administration proposal on lowering drug costs should ask Congress to allow private insurance companies to negotiate prices for drugs administered in a doctor’s office or hospital, two Republican policy experts said.
The administration’s proposal is a request for comment on strategies to lower drug prices and out-of-pocket costs. It was originally expected to be released in tandem with a speech by President Donald Trump on Thursday, but the speech was delayed as Health and Human Services Secretary Alex Azar recovers from an infection.
The heads of multiple health agencies told a House subcommittee Thursday that both the government and industry need to invest more resources in researching new forms of flu vaccines in light of this year’s epidemic.
Vaccines are often developed using egg-based technology, but newer cell-based and recombinant DNA technologies offer more speed and flexibility for fighting viruses — like the flu — that mutate frequently. While the technology offers promise, it remains uncommon, with lingering gaps in technology.
Industry groups and policy experts are questioning a Trump administration proposal on health insurance even as it garners accolades from congressional Republicans.
The proposed rule, announced on Thursday, would loosen regulations under the Employee Retirement Income Security Act, or ERISA, that govern association health plans. Such plans allow businesses to band together in purchasing health insurance. Supporters say the rule is intended to help consumers hit the hardest by rising premiums under the 2010 health care law.
Political appointees at the Department of Health and Human Services include at least 16 staffers with ties to former Secretary Tom Price and at least 12 with connections to Vice President Mike Pence or Indiana, a review of 129 résumés of appointed staffers in the department shows.
Pence’s influence over the agency can be seen in the appointment of Centers for Medicare and Medicaid Services Administrator Seema Verma, who worked closely with the former Indiana governor to expand Medicaid in that state, and the appointment of Verma’s deputy Brian Neale, who currently oversees Medicaid and served as Pence’s health care policy director in Indiana. A number of staffers also have ties to conservative groups close to Pence, such as the Heritage Foundation and anti-abortion organizations.
The House Administration Committee unanimously adopted on Wednesday a change in the member handbook that could help Democrats seeking to promote HealthCare.gov.
The new rule allows lawmakers to promote and link to federal government websites besides their own. Democrats had encountered the hurdle while attempting to promote the federal health insurance exchange through taxpayer-funded advertisements, known as franking.
House Republicans are working to resolve a dispute over rules that Democrats say are stopping them from promoting the health insurance exchanges.
Currently, lawmakers are prohibited from linking to any website other than their own in taxpayer-funded advertisements. Rep. Rodney Davis is proposing to allow them to link to other federal government websites, including HealthCare.gov.
When Chris Raymond called her insurance company recently to get the price of a brain scan, she came prepared. Or so she thought.
Raymond’s experience as a former medical reporter for the Journal of the American Medical Association gives her an edge over the typical patient trying to navigate the fractured health care system. As an active middle-aged woman who still plays recreational basketball, Raymond has also suffered enough injuries to understand the system from the patient perspective.
Attempts by House Democrats to promote open enrollment in the health care marketplaces are running up against arcane rules and what they call partisan politics. Lawmakers are seeking to compensate for reduced marketing on the part of the Trump administration with their own taxpayer-funded ads.
The Department of Health and Human Services earlier this year slashed advertising for HealthCare.gov by 90 percent, prompting cries of “sabotage” from Democrats and consumer advocates. House Democrats are trying to fill that gap through their own ads on social media and other outlets, but are being thwarted by Republicans on the Franking Commission who say the advertisements do not comply with congressional rules.
Save for later